A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma
Clinical trial NCT00429312 · COMPLETED
Trial details
- NCT number
- NCT00429312
- Sponsor
- Jennerex Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2008-02-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.